The $10,000 prize was awarded during the fifth edition of the event, held May 16 at Kyle Field on the campus of Texas A&M University in College Station.
SABER is collaborating with Texas A&M Biomedical Engineering to develop an antimicrobial bandage utilizing the emission of blue light for application on post-operative incisions and wounds. According to the company, the bandage would help prevent bacterial contamination and reduce surgical site infections. Blue light therapy has been proven to inactivate many clinical pathogens and bacteria and improve wound healing.
“We want to thank the Brazos Valley Economic Development Corporation for this money that will help us get our SBIR (Small Business Innovation Research) Phase II grant,” said Dr. Alan Glowczwski, the chief medical officer for SABER Corporation.
The Launch Prize is given to a company in the TNVC which maintains core operations and a business location in Brazos County. It is intended to contribute to the venture’s accelerated market entry.
The TNVC is spearheaded by the commercialization team at the Texas A&M Engineering Experiment Station (TEES) in conjunction with additional elements of the Texas A&M University System, headquartered in College Station. The event promotes the commercialization of emerging technology and recognizes Texas-based companies with high-growth potential. Seed funding serves to help the companies execute ideas and advance product development.
“In past years, we have had exciting startups that have won at this event and leveraged this to achieve significant success in raising follow-on capital investments as they pursue their journey to build companies that will impact the economy of the state and beyond,” said Dr. Balakrishna Haridas, the executive director of TEES’s Division of Commercialization & Entrepreneurship.
Sixteen companies – four of which maintain operations and a business location in Brazos County – took part in the day-long event starting with morning semifinals. Six of the 16 advanced to the finals in the afternoon, presenting to judges and audience members and taking questions. Companies also entered the afternoon’s elevator pitch competition, which featured live voting from audience members after a one-minute presentation.
Spark Biomedical, focused on non-invasive bioelectric medicine for treating neurological and psychiatric disorders, earned the overall top prize at the 2019 TNVC. PolyVascular, which is creating polymeric transcatheter valves for children with congenital heart disease, was awarded the elevator pitch prize. SABER Corporation finished second in the elevator pitch.
More than $500,000 in prize money was awarded at the 2019 TNVC. The BVEDC was a gold sponsor. For the full results, click here.